Retatrutide 20 MG

Retatrutide is an investigational peptide that activates three receptors simultaneously: GLP-1, GIP, and glucagon receptors. It is currently being studied for obesity and metabolic disease and has shown some of the most impressive weight-loss results seen in clinical trials.  

Scientifically Supported Benefits of Retatrutide

✅ Significant Weight Loss

• Phase 2 studies demonstrated average weight reductions of up to 24.2% of body weight at 48 weeks.
• More recent Phase 3 data reported average weight loss approaching 28% over 80 weeks in some participants.  

✅ Reduced Appetite and Food Intake

• GLP-1 and GIP receptor activation help reduce hunger, increase satiety, and decrease calorie consumption.